Cargando…

Development of spiro-3-indolin-2-one containing compounds of antiproliferative and anti-SARS-CoV-2 properties

A series of 1″-(alkylsulfonyl)-dispiro[indoline-3,2′-pyrrolidine-3′,3″-piperidine]-2,4″-diones 6a‒o has been synthesized through regioselective multi-component azomethine dipolar cycloaddition reaction of 1-(alkylsulfonyl)-3,5-bis(ylidene)-piperidin-4-ones 3a‒h. X-ray diffraction studies (6b‒d,h) co...

Descripción completa

Detalles Bibliográficos
Autores principales: Fawazy, Nehmedo G., Panda, Siva S., Mostafa, Ahmed, Kariuki, Benson M., Bekheit, Mohamed S., Moatasim, Yassmin, Kutkat, Omnia, Fayad, Walid, El-Manawaty, May A., Soliman, Ahmed A. F., El-Shiekh, Riham A., Srour, Aladdin M., Barghash, Reham F., Girgis, Adel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380671/
https://www.ncbi.nlm.nih.gov/pubmed/35974029
http://dx.doi.org/10.1038/s41598-022-17883-9
_version_ 1784768923371044864
author Fawazy, Nehmedo G.
Panda, Siva S.
Mostafa, Ahmed
Kariuki, Benson M.
Bekheit, Mohamed S.
Moatasim, Yassmin
Kutkat, Omnia
Fayad, Walid
El-Manawaty, May A.
Soliman, Ahmed A. F.
El-Shiekh, Riham A.
Srour, Aladdin M.
Barghash, Reham F.
Girgis, Adel S.
author_facet Fawazy, Nehmedo G.
Panda, Siva S.
Mostafa, Ahmed
Kariuki, Benson M.
Bekheit, Mohamed S.
Moatasim, Yassmin
Kutkat, Omnia
Fayad, Walid
El-Manawaty, May A.
Soliman, Ahmed A. F.
El-Shiekh, Riham A.
Srour, Aladdin M.
Barghash, Reham F.
Girgis, Adel S.
author_sort Fawazy, Nehmedo G.
collection PubMed
description A series of 1″-(alkylsulfonyl)-dispiro[indoline-3,2′-pyrrolidine-3′,3″-piperidine]-2,4″-diones 6a‒o has been synthesized through regioselective multi-component azomethine dipolar cycloaddition reaction of 1-(alkylsulfonyl)-3,5-bis(ylidene)-piperidin-4-ones 3a‒h. X-ray diffraction studies (6b‒d,h) confirmed the structures. The majority of the synthesized analogs reveal promising antiproliferation properties against a variety of human cancer cell lines (MCF7, HCT116, A431 and PaCa2) with good selectivity index towards normal cell (RPE1). Some of the synthesized agents exhibit potent inhibitory properties against the tested cell lines with higher efficacies than the standard references (sunitinib and 5-fluorouracil). Compound 6m is the most potent. Multi-targeted inhibitory properties against EGFR and VEGFR-2 have been observed for the synthesized agents. Flow cytometry supports the antiproliferation properties and shows the tested agents as apoptosis and necrosis forming. Vero cell viral infection model demonstrates the anti-SARS-CoV-2 properties of the synthesized agents. Compound 6f is the most promising (about 3.3 and 4.8 times the potency of the standard references, chloroquine and hydroxychloroquine). QSAR models explain and support the observed biological properties.
format Online
Article
Text
id pubmed-9380671
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-93806712022-08-17 Development of spiro-3-indolin-2-one containing compounds of antiproliferative and anti-SARS-CoV-2 properties Fawazy, Nehmedo G. Panda, Siva S. Mostafa, Ahmed Kariuki, Benson M. Bekheit, Mohamed S. Moatasim, Yassmin Kutkat, Omnia Fayad, Walid El-Manawaty, May A. Soliman, Ahmed A. F. El-Shiekh, Riham A. Srour, Aladdin M. Barghash, Reham F. Girgis, Adel S. Sci Rep Article A series of 1″-(alkylsulfonyl)-dispiro[indoline-3,2′-pyrrolidine-3′,3″-piperidine]-2,4″-diones 6a‒o has been synthesized through regioselective multi-component azomethine dipolar cycloaddition reaction of 1-(alkylsulfonyl)-3,5-bis(ylidene)-piperidin-4-ones 3a‒h. X-ray diffraction studies (6b‒d,h) confirmed the structures. The majority of the synthesized analogs reveal promising antiproliferation properties against a variety of human cancer cell lines (MCF7, HCT116, A431 and PaCa2) with good selectivity index towards normal cell (RPE1). Some of the synthesized agents exhibit potent inhibitory properties against the tested cell lines with higher efficacies than the standard references (sunitinib and 5-fluorouracil). Compound 6m is the most potent. Multi-targeted inhibitory properties against EGFR and VEGFR-2 have been observed for the synthesized agents. Flow cytometry supports the antiproliferation properties and shows the tested agents as apoptosis and necrosis forming. Vero cell viral infection model demonstrates the anti-SARS-CoV-2 properties of the synthesized agents. Compound 6f is the most promising (about 3.3 and 4.8 times the potency of the standard references, chloroquine and hydroxychloroquine). QSAR models explain and support the observed biological properties. Nature Publishing Group UK 2022-08-16 /pmc/articles/PMC9380671/ /pubmed/35974029 http://dx.doi.org/10.1038/s41598-022-17883-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Fawazy, Nehmedo G.
Panda, Siva S.
Mostafa, Ahmed
Kariuki, Benson M.
Bekheit, Mohamed S.
Moatasim, Yassmin
Kutkat, Omnia
Fayad, Walid
El-Manawaty, May A.
Soliman, Ahmed A. F.
El-Shiekh, Riham A.
Srour, Aladdin M.
Barghash, Reham F.
Girgis, Adel S.
Development of spiro-3-indolin-2-one containing compounds of antiproliferative and anti-SARS-CoV-2 properties
title Development of spiro-3-indolin-2-one containing compounds of antiproliferative and anti-SARS-CoV-2 properties
title_full Development of spiro-3-indolin-2-one containing compounds of antiproliferative and anti-SARS-CoV-2 properties
title_fullStr Development of spiro-3-indolin-2-one containing compounds of antiproliferative and anti-SARS-CoV-2 properties
title_full_unstemmed Development of spiro-3-indolin-2-one containing compounds of antiproliferative and anti-SARS-CoV-2 properties
title_short Development of spiro-3-indolin-2-one containing compounds of antiproliferative and anti-SARS-CoV-2 properties
title_sort development of spiro-3-indolin-2-one containing compounds of antiproliferative and anti-sars-cov-2 properties
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380671/
https://www.ncbi.nlm.nih.gov/pubmed/35974029
http://dx.doi.org/10.1038/s41598-022-17883-9
work_keys_str_mv AT fawazynehmedog developmentofspiro3indolin2onecontainingcompoundsofantiproliferativeandantisarscov2properties
AT pandasivas developmentofspiro3indolin2onecontainingcompoundsofantiproliferativeandantisarscov2properties
AT mostafaahmed developmentofspiro3indolin2onecontainingcompoundsofantiproliferativeandantisarscov2properties
AT kariukibensonm developmentofspiro3indolin2onecontainingcompoundsofantiproliferativeandantisarscov2properties
AT bekheitmohameds developmentofspiro3indolin2onecontainingcompoundsofantiproliferativeandantisarscov2properties
AT moatasimyassmin developmentofspiro3indolin2onecontainingcompoundsofantiproliferativeandantisarscov2properties
AT kutkatomnia developmentofspiro3indolin2onecontainingcompoundsofantiproliferativeandantisarscov2properties
AT fayadwalid developmentofspiro3indolin2onecontainingcompoundsofantiproliferativeandantisarscov2properties
AT elmanawatymaya developmentofspiro3indolin2onecontainingcompoundsofantiproliferativeandantisarscov2properties
AT solimanahmedaf developmentofspiro3indolin2onecontainingcompoundsofantiproliferativeandantisarscov2properties
AT elshiekhrihama developmentofspiro3indolin2onecontainingcompoundsofantiproliferativeandantisarscov2properties
AT srouraladdinm developmentofspiro3indolin2onecontainingcompoundsofantiproliferativeandantisarscov2properties
AT barghashrehamf developmentofspiro3indolin2onecontainingcompoundsofantiproliferativeandantisarscov2properties
AT girgisadels developmentofspiro3indolin2onecontainingcompoundsofantiproliferativeandantisarscov2properties